Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Class I Medtronic Defibrillator Recall Associated With Faulty Capacitor

This article was originally published in The Gray Sheet

Executive Summary

Medtronic acknowledges it underestimated an ICD capacitor problem in 1999 now at the root of the firm's decision to recall two defibrillator product lines

You may also be interested in...



Lack Of Device Identifiers On Recalled Cardiac Devices Cost Medicare $1.5Bn, OIG Says

Medicare lost $1.5bn in claims over a 10-year period to cover procedures to fix or replace seven faulty cardiac devices due to the lack of product-specific information on its claims form for malfunctioning defibrillators and pacemakers, says the US HHS Office of Inspector General. Recalls of Medtronic, Boston Scientific and Abbott/St. Jude Medical cardiac rhythm management devices are likely behind most of the cost.

Paradigm Quick-Set Plus Is Second Medtronic Class I Recall Within A Month

Medtronic MiniMed estimates 200,000 Paradigm Quick-set Plus insulin infusion sets remain in U.S. distribution following a firm-initiated, Class I recall

Paradigm Quick-Set Plus Is Second Medtronic Class I Recall Within A Month

Medtronic MiniMed estimates 200,000 Paradigm Quick-set Plus insulin infusion sets remain in U.S. distribution following a firm-initiated, Class I recall

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020109

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel